Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Pharmacology|February 22, 2021
Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitroHua-Long Xiong, Jia-Li Cao, Chen-Guang Shen, et al.Theranostics|June 6, 2022
Erratum: A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: ErratumJun-Fang Zhang, Hua-Long Xiong, Jia-Li Cao, et al.Emerging Microbes & Infections|May 28, 2019
Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virusYa-Li Zhang, Ying Gao, Jia-Li Cao, et al.Theranostics|January 2, 2018
A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathwayJun-Fang Zhang, Hua-Long Xiong, Jia-Li Cao, et al.British Journal of Pharmacology|January 20, 2026
Empty lipid nanoparticles (eLNPs) with adjuvant activity induce potent immune responsesDe-Kui Qiu, Si-Ping Yan, Rui-Tong Chen, et al.Nature Communications|July 21, 2019
Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interactionTian-Ying Zhang, Hong-Ying Chen, Jia-Li Cao, et al.Cellular & Molecular Immunology|March 2, 2023
A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19Lin Xia, Lun-Zhi Yuan, Ya-Hong Hu, et al.Emerging Microbes & Infections|September 7, 2020
Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cellsHua-Long Xiong, Yang-Tao Wu, Jia-Li Cao, et al.Gut|March 31, 2019
A unique B cell epitope-based particulate vaccine shows effective suppression of hepatitis B surface antigen in miceTian-Ying Zhang, Xue-Ran Guo, Yang-Tao Wu, et al.Pageof 1